Position in SPRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,903,945
-$2,793,244 QoQ
Shares Held
610,703
-7.6% QoQ
Ownership
0.615%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nextech Invest, Ltd. holds $1,421,052,371 across 17 Biotechnology names. SPRY ranks #17 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
7,601,087 | $739,205,710 | |
| 2 | TYRA |
Tyra Biosciences, Inc.
|
4,055,861 | $155,339,476 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
7,266,081 | $152,006,414 | |
| 4 | ORIC |
Oric Pharmaceuticals, Inc.
|
7,162,637 | $90,750,610 | |
| 5 | ALMS |
Alumis Inc.
|
3,540,998 | $78,008,185 | |
| 6 | RLAY |
Relay Therapeutics, Inc.
|
5,526,506 | $54,988,734 | |
| 7 | ZYME |
Zymeworks Inc.
|
1,113,946 | $27,893,207 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
278,896 | $23,229,247 |
All Filings in SPRY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,903,945 | 610,703 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,697,189 | 660,703 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,640,065 | 660,703 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,943,171 | 741,729 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,784,050 | 936,729 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||